An Unexpected Finding: Treatment History Associated with the Quality of Life in Chinese Patients with Port-Wine Stains.

Skindex-29 dermatology life quality index port-wine stains quality of life

Journal

Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449

Informations de publication

Date de publication:
2023
Historique:
received: 30 05 2023
accepted: 18 07 2023
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: epublish

Résumé

Port-wine stains (PWS) are predominantly located on the face and neck. Hence, PWS affect not only aesthetic appearance but may also cause psychological distress. However, very few studies have researched on the quality of life (QoL) in Chinese patients with PWS. To evaluate QoL in patients with PWS. Skindex-29 and Dermatology Life Quality Index (DLQI) were used to investigate the QoL of the patients with PWS and healthy controls. In total, 198 adults with PWS and 200 healthy controls were included. The scores of symptomatic, emotional and functional dimensions of Skindex-29 in the observational group were significantly higher as compared with the control group ( The QoL of patients with PWS is impaired. Patients' QoL is negatively influenced by female gender, lesion location and treatment history. The Skindex-29 scale seems to be more applicable to the study of QoL of patients with PWS.

Sections du résumé

Background UNASSIGNED
Port-wine stains (PWS) are predominantly located on the face and neck. Hence, PWS affect not only aesthetic appearance but may also cause psychological distress. However, very few studies have researched on the quality of life (QoL) in Chinese patients with PWS.
Aim UNASSIGNED
To evaluate QoL in patients with PWS.
Methods and Materials UNASSIGNED
Skindex-29 and Dermatology Life Quality Index (DLQI) were used to investigate the QoL of the patients with PWS and healthy controls.
Results UNASSIGNED
In total, 198 adults with PWS and 200 healthy controls were included. The scores of symptomatic, emotional and functional dimensions of Skindex-29 in the observational group were significantly higher as compared with the control group (
Conclusion UNASSIGNED
The QoL of patients with PWS is impaired. Patients' QoL is negatively influenced by female gender, lesion location and treatment history. The Skindex-29 scale seems to be more applicable to the study of QoL of patients with PWS.

Identifiants

pubmed: 37533495
doi: 10.2147/CCID.S421296
pii: 421296
pmc: PMC10391529
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1969-1975

Informations de copyright

© 2023 Zhao et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Br J Dermatol. 2006 Feb;154(2):325-31
pubmed: 16433804
Acta Derm Venereol. 2021 Apr 27;101(4):adv00439
pubmed: 33372685
Clin Cosmet Investig Dermatol. 2021 Jun 22;14:681-690
pubmed: 34188511
J Eur Acad Dermatol Venereol. 2011 Aug;25(8):969-72
pubmed: 21108662
Br J Dermatol. 2002 Mar;146(3):440-7
pubmed: 11952544
Br J Dermatol. 1998 Aug;139(2):173-7
pubmed: 9767228
Qual Life Res. 2018 Dec;27(12):3209-3215
pubmed: 30203303
Lupus. 2021 May;30(6):972-980
pubmed: 33663251
J Am Acad Dermatol. 2017 Apr;76(4):695-702
pubmed: 27955934
Medicine (Baltimore). 2017 Dec;96(51):e9446
pubmed: 29390578
Br J Dermatol. 2012 Apr;166(4):884-7
pubmed: 22229951
Dermatol Surg. 2003 Jan;29(1):49-55
pubmed: 12534512
Br J Dermatol. 2000 Dec;143(6):1230-4
pubmed: 11122026
Br J Plast Surg. 1997 Sep;50(6):463-7
pubmed: 9326151
Dermatol Res Pract. 2019 Apr 2;2019:6879412
pubmed: 31065260
Br J Dermatol. 1989 Aug;121(2):209-15
pubmed: 2775645
J Investig Dermatol Symp Proc. 2004 Mar;9(2):169-80
pubmed: 15083785
Br J Dermatol. 2022 May;186(5):861-874
pubmed: 34748646
Arch Dermatol. 1994 Jul;130(7):879-83
pubmed: 7517655
Br J Dermatol. 2019 Oct;181(4):770-777
pubmed: 30729508
Pediatrics. 1976 Aug;58(2):218-22
pubmed: 951136
Dermatol Clin. 2012 Apr;30(2):231-6, xiii
pubmed: 22284137

Auteurs

Qian Zhao (Q)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Department of Medical Cosmetology, Chengdu Second People's Hospital, Chengdu, Sichuan, 610021, People's Republic of China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Lian Liu (L)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Xiaoxue Li (X)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Lihua Yang (L)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Xian Jiang (X)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology (CIII), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Classifications MeSH